关于植物体作为一种新兴技术,用于提供草药的综合性审查
Preeti Aneja1, Rajender Guleria1, Shivali Aneja2
1Department of Pharmaceutics, Abhilashi College of Pharmacy, Nerchowk, Mandi, Himachal Pradesh, 175008, India.
Journal of Asian natural products research
|October 8, 2025
概括
植物体提供了先进的草药输送系统,以提高天然药物的吸收和有效性. 这种新的药物输送系统克服了植物提取物中常见的溶解性和吸收性问题.
科学领域:
- 药理学 药理学 是一个学科.
- 自然产品化学 自然产品化学
- 药物输送系统 药物输送系统
背景情况:
- 传统的药物输送方法在给药天然化合物方面存在局限性.
- 植物提取物和化合物通常具有较差的溶解性和吸收性,阻碍了它们的治疗疗效.
- 植物体代表了一种先进的方法来克服自然医学交付中的这些挑战.
研究的目的:
- 审查植物体技术在天然药物输送方面的进展.
- 突出植物体的实际好处和成本效益.
- 讨论植物体作为一种新型药物输送系统的潜力.
主要方法:
- 关于植物体和草本药物输送的科学出版物的文献综述.
- 对研究的分析表明,植物体配方的吸收和有效性得到改善.
- 对植物体生产和应用的成本效益数据的评估.
主要成果:
- 植物体显著提高了植物衍生化合物的生物可用性和治疗效果.
- 这种新的药物输送系统解决了天然药物的可溶性和吸收限制.
- 植物体技术在各种应用中提供了实用优势,并证明了成本效益.
结论:
- 植物体是天然药物的有希望和有效的新型药物输送系统.
- 该技术提高了植物提取物的吸收和有效性,克服了传统的局限性.
- 植物体为促进草药的发展提供了具有成本效益和实用的解决方案.
相关概念视频
Bioavailability Enhancement: Drug Permeability Enhancement
186
Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...
186
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
180
Body:Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug...
180
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
149
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
149
Cellular Membranes and Drug Transport
1.4K
Drugs must traverse multiple biological barriers, such as multi-layered skin, single-layered intestinal epithelium, and the plasma membrane, to reach their target sites within the body. The plasma membrane, a highly structured composite of phospholipids, carbohydrates, and proteins, is the cell's protective boundary, facilitating selective substance exchange.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
1.4K
Bioavailability Enhancement: Drug Solubility Enhancement
221
Body:Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
221
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
196
Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
196


